1. Home
  2. SNTG vs NCNA Comparison

SNTG vs NCNA Comparison

Compare SNTG & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTG
  • NCNA
  • Stock Information
  • Founded
  • SNTG 2009
  • NCNA 1997
  • Country
  • SNTG China
  • NCNA United Kingdom
  • Employees
  • SNTG N/A
  • NCNA N/A
  • Industry
  • SNTG Finance: Consumer Services
  • NCNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNTG Finance
  • NCNA Health Care
  • Exchange
  • SNTG Nasdaq
  • NCNA Nasdaq
  • Market Cap
  • SNTG 4.8M
  • NCNA 4.5M
  • IPO Year
  • SNTG 2021
  • NCNA 2017
  • Fundamental
  • Price
  • SNTG $1.94
  • NCNA $0.06
  • Analyst Decision
  • SNTG
  • NCNA Buy
  • Analyst Count
  • SNTG 0
  • NCNA 2
  • Target Price
  • SNTG N/A
  • NCNA $25.00
  • AVG Volume (30 Days)
  • SNTG 7.3K
  • NCNA 283.2M
  • Earning Date
  • SNTG 08-05-2025
  • NCNA 08-14-2025
  • Dividend Yield
  • SNTG N/A
  • NCNA N/A
  • EPS Growth
  • SNTG N/A
  • NCNA N/A
  • EPS
  • SNTG N/A
  • NCNA N/A
  • Revenue
  • SNTG $107,507.00
  • NCNA N/A
  • Revenue This Year
  • SNTG N/A
  • NCNA N/A
  • Revenue Next Year
  • SNTG N/A
  • NCNA N/A
  • P/E Ratio
  • SNTG N/A
  • NCNA N/A
  • Revenue Growth
  • SNTG N/A
  • NCNA N/A
  • 52 Week Low
  • SNTG $1.43
  • NCNA $0.03
  • 52 Week High
  • SNTG $3.52
  • NCNA $10.79
  • Technical
  • Relative Strength Index (RSI)
  • SNTG 53.91
  • NCNA 42.17
  • Support Level
  • SNTG $1.93
  • NCNA $0.04
  • Resistance Level
  • SNTG $1.96
  • NCNA $0.07
  • Average True Range (ATR)
  • SNTG 0.08
  • NCNA 0.01
  • MACD
  • SNTG -0.01
  • NCNA 0.01
  • Stochastic Oscillator
  • SNTG 30.36
  • NCNA 13.10

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: